MedPath

Het staken van antiobiotica op geleide van een biomarker, procalcitonine bij volwassen patienten opgenomen op de intensive care unit.

Conditions
Antibiotics/ AntibioticaInfection/ InfectieProcalcitonin/ ProcalcitonineBiomarker/ Biomarker
Registration Number
NL-OMON21923
Lead Sponsor
not applicable
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
2246
Inclusion Criteria

Any patient over the age of 18, admitted to the ICU and receiving antibiotics for an assumed infection can be enrolled into this trial. Informed consent has to be obtained in writing from the patient of his/her relatives prior to inclusion.

Exclusion Criteria

1. Failure to obtain written consent to participate;

2. Patients receiving prolonged antibiotic therapies (> 3 weeks, e.g. endocarditis);

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath